Main sector:
Pharma (fully integrated)
Subsectors:
Antibodies
Anti-infectives
Gene therapy
Generics
Small molecule therapeutics
Vaccines
Indications:
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Pregnancy, childbirth and the puerperium / obstetrics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Injury, poisoning and certain other consequences of external causes / toxicology
Products
In development: 112
On the market: 35
Description:
GSK plc engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease. The company offers pharmaceutical products comprising medicines in the therapeutic areas such as infectious disease, HIV, immunology and respiratory, and oncology. The company also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company's products include BLUJEPA a triazaacenaphthylene bacterial type II topoisomerase...
